Literature DB >> 15094767

Targets and mechanisms for the regulation of translation in malignant transformation.

Michael J Clemens1.   

Abstract

There is increasing evidence that deregulation of gene expression at the level of mRNA translation can contribute to cell transformation and the malignant phenotype. Two steps in the pathway of polypeptide chain initiation, viz. the assembly of the 43S initiation complex catalysed by polypeptide chain initiation factor eIF2 and the binding of eIF4E to eIF4G during the recruitment of mRNA to the ribosome, have been shown to be likely targets for changes associated with tumorigenesis. The activity of eIF2 is controlled by changes in phosphorylation of the alpha subunit of this factor. The availability of eIF4E for binding to eIF4G is regulated by the phosphorylation of a small family of eIF4E-binding proteins (the 4E-BPs). The activities of the protein kinases and/or phosphatases responsible for the (de)phosphorylation of these substrates may in turn be controlled by cellular and viral oncogenes and tumour-suppressor genes. This review will describe recent aspects of the mechanisms involved, with particular emphasis on the regulation of the eIF2 alpha kinase PKR and the control of 4E-BP phosphorylation by viral gene products, growth-inhibitory cytokines and the tumour-suppressor protein p53.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094767     DOI: 10.1038/sj.onc.1207544

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  68 in total

1.  Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.

Authors:  Yikun Li; Ping Yue; Xingming Deng; Takeshi Ueda; Rikiro Fukunaga; Fadlo R Khuri; Shi-Yong Sun
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

2.  eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression.

Authors:  Luc Furic; Liwei Rong; Ola Larsson; Ismaël Hervé Koumakpayi; Kaori Yoshida; Andrea Brueschke; Emmanuel Petroulakis; Nathaniel Robichaud; Michael Pollak; Louis A Gaboury; Pier Paolo Pandolfi; Fred Saad; Nahum Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

3.  Constant IFNgamma mRNA to protein ratios in cord and adult blood T cells suggests regulation of IFNgamma expression in cord blood T cells occurs at the transcriptional level.

Authors:  A Kumar Gupta; C Rusterholz; W Holzgreve; S Hahn
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

Review 4.  An integrated strategy for the optimization of microarray data interpretation.

Authors:  Xinmin Li; Richard J Quigg
Journal:  Gene Expr       Date:  2005

5.  Mapping of the auto-inhibitory interactions of protein kinase R by nuclear magnetic resonance.

Authors:  Vladimir Gelev; Huseyin Aktas; Assen Marintchev; Takuhiro Ito; Dominique Frueh; Michael Hemond; David Rovnyak; Mirijam Debus; Sven Hyberts; Anny Usheva; Jose Halperin; Gerhard Wagner
Journal:  J Mol Biol       Date:  2006-09-01       Impact factor: 5.469

6.  Fibronectin controls cap-dependent translation through beta1 integrin and eukaryotic initiation factors 4 and 2 coordinated pathways.

Authors:  Chiara Gorrini; Fabrizio Loreni; Valentina Gandin; Leonardo A Sala; Nahum Sonenberg; Pier Carlo Marchisio; Stefano Biffo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-16       Impact factor: 11.205

7.  FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.

Authors:  Olga V Danilova; Larry J Dumont; Norman B Levy; Frederick Lansigan; William B Kinlaw; Alexey V Danilov; Prabhjot Kaur
Journal:  J Hematop       Date:  2013-03       Impact factor: 0.196

8.  Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1.

Authors:  Kerrington D Smith; James J Mezhir; Kai Bickenbach; Jula Veerapong; Jean Charron; Mitchell C Posner; Bernard Roizman; Ralph R Weichselbaum
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

9.  The adenovirus E1B 55-kilodalton and E4 open reading frame 6 proteins limit phosphorylation of eIF2alpha during the late phase of infection.

Authors:  Megan E Spurgeon; David A Ornelles
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

Review 10.  Enhancing mTOR-targeted cancer therapy.

Authors:  Xuerong Wang; Shi-Yong Sun
Journal:  Expert Opin Ther Targets       Date:  2009-10       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.